Optimi Health beefs psychedelic footprint, nabs new funding

https://s43720.pcdn.co/wp-content/uploads/2025/01/optimipsilocybinmdma-1280x803.jpg

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) raised nearly C$1 million in fresh capital as it continues to expand production internationally.

The psychedelics supplier closed the second tranche of its private placement Tuesday, raising C$395,000 and bringing total proceeds to C$934,000. The financing, which saw participation from company insiders,…

Please login to read all 288 words.

Leave a Reply

Your email address will not be published. Required fields are marked *